Adult Immunization Allergy & Immunology Cardiology Dermatology Endocrinology Gastroenterology Infectious Disease Men’s Health Nephrology Neurology Pain Management Pediatric Immunization Pediatrics Psychiatry Pulmonology Rheumatology Screening Women’s Health

Billing and Collections Career Planning Coding and Documentation Concierge Medicine Cybersecurity EHRs Investing Patient Relations Personal Finance Practice Management Remote Patient Monitoring Staffing Technology Telehealth Value-based Care

VMS and Menopause T1D: Paving the Path to Prevention Adult Immunization Center Dermatology Hot Topics

Saud A. Sadiq, MD

home / authors / saud-sadiq-md

Articles

Intrathecal Methotrexate: A Treatment Option for Patients With Progressive Multiple Sclerosis?

Intrathecal Methotrexate: A Treatment Option for Patients With Progressive Multiple Sclerosis?

Saud A. Sadiq, MD

November 14th 2012

Could intrathecally administered methotrexate be a viable treatment option for your patients with progressive forms of multiple sclerosis?

Terms and Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.